作者:Alexander Pasternak、Stephen D. Goble、Mary Struthers、Pasquale P. Vicario、Julia M. Ayala、Jerry Di Salvo、Ruth Kilburn、Thomas Wisniewski、Julie A. DeMartino、Sander G. Mills、Lihu Yang
DOI:10.1021/ml900009d
日期:2010.4.8
This report describes the discovery of a potent, orally bioavailable CC chemokine receptor 2 (CCR2) antagonist which, while optimized for CCR2 potency, also had potent CC chemokine receptor 5 (CCR5) activity